Vitrafy will configure its cryopreservation ecosystem specifically for red blood cells at Hoxworth Blood Center, deploying one Guardion freezing unit and its LifeChain software package during the first half of FY27. Both organisations are contributing resources and in-kind support, with no revenue expected initially. …
What the notice confirms is that Oakridge issued 4,999,943 fully paid ordinary shares, dated 30 June 2026. Company secretary Julie Edwards is named on the filing. Beyond that, the notice is procedural: it does not set out the placement price, the parties who subscribed …
Hoxworth Blood Center, founded in 1938, operates as part of the University of Cincinnati and is described as one of the oldest blood centres in the United States. Vitrafy's announcement noted that Hoxworth runs seven collection sites, collected roughly 1% of total US blood …
Sonic Healthcare Ltd (ASX: SHL) traded at AUD 20.80, down 0.024%, during the afternoon trading session on 23 July 2026. While the stock remained broadly unchanged during the session, it continues to trade 25.63% lower over the past year. Meanwhile, the broader S&P/ASX 200 …
Polynovo Ltd trades on the ASX under the code PNV. It is broadly positioned as a medical device company specialising in wound care solutions. The company's activities and strategic direction place it within the healthcare space, an area that has seen varied levels of …
Global Health Limited (ASX:GLH) released its June 2026 Quarterly Business Activity Report and Appendix 4C, highlighting progress in completing a multi-year technology transformation, expanding its software-as-a-service (SaaS) platform and improving operating cash flow. The company also reported higher customer receipts, continued adoption of artificial …
CLINUVEL Pharmaceuticals Ltd (ASX:CUV) traded 1.62% higher at AUD 10.04 during the morning session on 23 July 2026 after unveiling a strategic reorganisation that will see the company relocate its corporate headquarters to the United States. While the stock remains down 15.84% over the …
Dimerix Ltd (ASX:DXB) traded 4.00% higher at AUD 0.26 during the morning session on 23 July 2026 after announcing a significant intellectual property milestone for its recently acquired drug candidate, DMX-652. Although the stock remains down 51.85% over the past year, investors appeared to …
Cochlear Ltd (ASX:COH) is a global leader in cochlear implant and hearing solutions, with devices sold in more than 180 countries. Its principal asset or activity is cochlear implants, bone anchored hearing systems and acoustic implants sold across more than 180 countries.
ResMed CDI (ASX:RMD) ended the 22 July 2026 trading session lower, closing at AUD 27.75, down 0.68% (AUD 0.19) for the day. The decline came during a weaker session for healthcare shares, with the S&P/ASX 200 Health Care Index (ASX:XHJ) falling 1.93%.